Menopausal hormones and breast cancer in a biracial population.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 1446270)

Published in Am J Public Health on June 01, 2000

Authors

P G Moorman1, H Kuwabara, R C Millikan, B Newman

Author Affiliations

1: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn., USA. patricia.moorman@yale.edu

Articles cited by this

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst (1994) 4.28

Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA (1997) 3.18

A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA (1991) 3.07

Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA (1995) 2.43

The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat (1995) 2.31

Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol (1999) 2.21

Randomized recruitment in case-control studies. Am J Epidemiol (1991) 2.19

Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res (1998) 1.76

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol (1997) 1.63

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol (1995) 1.59

Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (1998) 1.58

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health (1995) 1.49

Correlates of postmenopausal female hormone use among black women in the United States. Obstet Gynecol (1998) 1.49

Postmenopausal estrogen and the risk of breast cancer. Ann Epidemiol (1994) 1.46

Barriers to screening for breast cancer. Cancer (1992) 1.44

Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control (1994) 1.34

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol (1993) 1.31

Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat (1995) 1.21

Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol (1995) 1.18

Racial differences in risk factors for atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities. Angiology (1997) 1.11

Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol (1992) 1.01

Ovarian aging and hormone replacement therapy. Hormonal levels, symptoms, and attitudes of African-American and white women. J Gen Intern Med (1997) 0.89

Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol (1990) 0.87

Hormone replacement therapy: aspects of bleeding problems and compliance. Int J Fertil Menopausal Stud (1996) 0.85

Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint. J Intern Med (1995) 0.84

The menopausal experience of African American women: overview and suggestions for research. Health Care Women Int (1997) 0.83

Hormone replacement therapy in the menopause: a pro opinion. CA Cancer J Clin (1996) 0.83

African-American women's attitudes and expectations of menopause. Am J Prev Med (1997) 0.78

Postmenopausal hormone therapy and the risk of breast cancer. Maturitas (1999) 0.78

Articles by these authors

Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21

Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96

Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood (1990) 3.65

Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol (2000) 2.93

An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell (1989) 2.78

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA (1998) 2.76

Poisoning with maprotiline and mianserin. Br Med J (1977) 2.64

The health effects of swimming in ocean water contaminated by storm drain runoff. Epidemiology (1999) 2.58

Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood (1991) 2.47

Population attributable fraction estimation for established breast cancer risk factors: considering the issues of high prevalence and unmodifiability. Am J Epidemiol (1998) 2.27

Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol (1999) 2.21

Paracetamol poisoning in children. Br Med J (1978) 2.17

Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care (1999) 2.11

Effects of passive immunization on experimental syphilis in the rabbit. Johns Hopkins Med J (1973) 2.07

A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet (1997) 2.01

Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96

Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. Mol Biochem Parasitol (1991) 1.95

Demonstration of a virus-like agent contaminating material containing the Stockholm substrain of the Nichols pathogenic Treponema pallidum. Br J Vener Dis (1970) 1.74

Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev (1999) 1.74

Infectivity tests in syphilis. Br J Vener Dis (1969) 1.73

ELFT: a gene that directs the expression of an ELAM-1 ligand. Cell (1990) 1.70

Area-level characteristics and smoking in women. Am J Public Health (2001) 1.68

Are heavy smokers different from light smokers? A comparison after 48 hours without cigarettes. JAMA (1988) 1.65

Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63

Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (1998) 1.58

Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. Am J Epidemiol (2000) 1.58

Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res (2000) 1.55

Genetic and behavioral determinants of waist-hip ratio and waist circumference in women twins. Obes Res (1998) 1.53

Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am J Epidemiol (2003) 1.51

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51

A blocking monoclonal antibody to endothelial-leukocyte adhesion molecule-1 (ELAM1). Biochem Biophys Res Commun (1990) 1.50

Genetic and behavioral influences on body fat distribution. Int J Obes (1990) 1.43

The effect of short-term, temporary deferral on future blood donation. Transfusion (1998) 1.43

Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.43

Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet (1988) 1.42

Tumor characteristics in African American and white women. Breast Cancer Res Treat (2001) 1.39

Infectivity tests in syphilis. 1969. Sex Transm Infect (2000) 1.39

Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. Biochem Biophys Res Commun (1991) 1.37

Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr (1999) 1.35

Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.35

Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am J Epidemiol (1996) 1.35

Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. J Consult Clin Psychol (1990) 1.31

Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A (1994) 1.30

Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb (1994) 1.29

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group. J Infect Dis (1997) 1.28

Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins. Am J Hum Genet (1997) 1.28

Splenic lymphangiomatosis in children. Radiology (1997) 1.24

Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23

Venereal spirochetosis of rabbits (rabbit syphilis) due to Treponema cuniculi: a clinical, serological, and histopathological study. Lab Anim Sci (1972) 1.22

Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry. Breast Cancer Res Treat (1995) 1.21

Alcohol consumption and breast cancer among black and white women in North Carolina (United States). Cancer Causes Control (2000) 1.20

Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol (1992) 1.19

Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev (1998) 1.19

Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol (2001) 1.16

Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors. Lymphology (2008) 1.14

In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene (2008) 1.13

Interactive effects of depression symptoms, nicotine dependence, and weight change on late smoking relapse. J Consult Clin Psychol (1996) 1.12

Left mainstem bronchial narrowing: a vascular compression syndrome? Evaluation by magnetic resonance imaging. Pediatr Radiol (1998) 1.12

Subclinical Fabry's disease occurring in the context of IgA nephropathy. Clin Nephrol (1997) 1.11

Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation (1993) 1.11

Age at menarche, time to regular cycling, and breast cancer (North Carolina, United States). Cancer Causes Control (1998) 1.09

Quantitative autistic traits ascertained in a national survey of 22 529 Japanese schoolchildren. Acta Psychiatr Scand (2012) 1.09

Lactation and breast cancer risk. Int J Epidemiol (1999) 1.08

Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev (2000) 1.07

Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. Am J Hum Genet (1999) 1.07

Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A (1991) 1.06

Why be moral: Humanist and behavioral perspectives. Behav Anal (1996) 1.06

Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.05

The effects of phenotypic plasticity on genetic correlations. Trends Ecol Evol (1991) 1.05

Environmental and behavioral determinants of fasting plasma glucose in women. A matched co-twin analysis. Am J Epidemiol (1987) 1.05

Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care (1993) 1.04

Interest in genetic testing among first-degree relatives of colorectal cancer patients. Am J Prev Med (2000) 1.03

Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol (1999) 1.03

Risk of breast cancer according to the status of HER-2/neu oncogene amplification. Cancer Epidemiol Biomarkers Prev (2000) 1.03

Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int (1997) 1.02

Lack of suppressor cell activity in systemic lupus erythematosus. Clin Immunol Immunopathol (1979) 1.02

The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control (2000) 1.00

Bowel perforation in Hirschsprung's disease. AJR Am J Roentgenol (1987) 0.99

Oxygen consumption of cerebral cortex fails to increase during continued vibrotactile stimulation. J Cereb Blood Flow Metab (1999) 0.99

Menstrual risk factors and early-onset breast cancer. Cancer Causes Control (2000) 0.99

Inherited predisposition to breast and ovarian cancer. Am J Hum Genet (1994) 0.98

Oral contraceptives and breast cancer among African-american women and white women. J Natl Med Assoc (2001) 0.98

Program sustainability of a community-based intervention to prevent falls among older Australians. Health Promot Int (2004) 0.98

Acupuncture in the prevention of postoperative nausea and vomiting. Anaesthesia (1997) 0.98

Neural activation during performance of number-letter sequencing. Appl Neuropsychol (2000) 0.98

Theoretical aspects of saturation analysis. Acta Endocrinol Suppl (Copenh) (1970) 0.97

Prospective study of factors influencing the development of craving associated with smoking cessation. Psychopharmacology (Berl) (1991) 0.97

Population-based case-control study of occupational exposure to electromagnetic fields and breast cancer. Ann Epidemiol (2001) 0.97